Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Experience Is standing by: 10 Pleasant Setting up camp Areas to - 2Vote in favor of your #1 Kind of Cap
- 3Earthquake in Indonesia kills at least 1 person and sets off small tsunami
- 4Europe's powerful Ariane 6 rocket launches Sentinel-1D Earth-observation satellite to orbit (video)
- 5Activists guilty over Palestine protest breach
- Audits of 6 American Busssiness Class Flights
- The most effective method to Pick the Right Material Organization: Your Definitive Aide
- Step by step instructions to Show Children the Significance of Appropriate Handshaking
- A throat bone settles it - Nanotyrannus was not a juvenile T. rex
- Iranian president warns of retaliation against Gulf states
- From Fledgling to Master: Self-awareness in a Side interest
- 7 Countries Where Newcomers Feel Most Welcome, and 3 Where They Often Don’t
- French lawmakers narrowly approve health care budget, suspending Macron's flagship pension reform
- Etymological Experiences on the Wireless transmissions: A Survey of \Learning in a hurry\ Language Web recording
